Skip to main content

Table 1 Characteristics of the patients and tumors

From: Clustering subtypes of breast cancer by combining immunohistochemistry profiles and metabolism characteristics measured using FDG PET/CT

Characteristics

Hormonal

(n = 182)

HER2

(n = 24)

Dual Positive

(n = 47)

Triple Negative

(n = 36)

P

Age (y)

54.8 ± 11.0

55.6 ± 10.2

53.5 ± 9.4

55.5 ± 12.1

0.813

Histology

     

IDC

150

20

44

28

0.067

ILC

14

1

1

0

 

Others

8

3

2

8

 

T stage

     

T1

121

17

24

26

0.572

T2

54

7

21

10

 

T3

6

0

2

0

 

T4

1

0

0

0

 

N stage

    

0.165

N0

109

18

31

31

 

N1

56

6

11

5

 

N2

13

0

4

0

 

N3

4

0

1

0

 

Nuclear grade

    

< 0.001*

1

77

0

5

2

 

2

85

7

19

11

 

3

20

17

23

23

 

Stage

    

0.451

IA

84

15

17

23

 

IB

8

0

1

1

 

IIA

51

5

20

10

 

IIB

20

4

4

2

 

IIIA

14

0

4

0

 

IIIB

1

0

0

0

 

IIIC

4

0

1

0

 

Operation

    

0.256

BCS

119

13

25

28

 

MRM

52

9

19

8

 

SSM

11

2

3

0

 
  1. BCS breast conserving surgery, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, MRM modified radical mastectomy, SSM skin-sparing mastectomy; *P < 0.05
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us